Jeanne L. Linnenbringer - Sep 3, 2024 Form 4 Insider Report for CNO Financial Group, Inc. (CNO)

Role
Chief Operations Officer
Signature
Heidi M. Krings, Attorney-in-Fact
Stock symbol
CNO
Transactions as of
Sep 3, 2024
Transactions value $
-$355,174
Form type
4
Date filed
9/5/2024, 08:36 PM
Previous filing
Aug 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNO Common Stock Options Exercise $79.9K +4.6K +10.08% $17.38 50.2K Sep 3, 2024 Direct
transaction CNO Common Stock Sale -$26.7K -764 -1.52% $34.95 49.5K Sep 3, 2024 Direct F1, F2
transaction CNO Common Stock Sale -$160K -4.6K -9.3% $34.87 44.9K Sep 3, 2024 Direct F1, F2
transaction CNO Common Stock Sale -$61.8K -1.79K -3.98% $34.61 43.1K Sep 4, 2024 Direct F1, F3
transaction CNO Common Stock Sale -$186K -5.44K -12.61% $34.26 37.7K Sep 5, 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNO Employee Stock Option (Right to Buy) Options Exercise $0 -4.6K -100% $0.00 0 Sep 3, 2024 Common Stock 4.6K $17.38 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2024.
F2 Reflects weighted average sale price. Sales ranged from $34.67 per share to $35.15 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F3 Reflects weighted average sale price. Sales ranged from $34.48 per share to $34.78 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F4 Reflects weighted average sale price. Sales ranged from $33.97 per share to $34.70 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F5 One-half of these stock options vested on February 23, 2018, and one-half vested on February 23, 2019.